Skip to main content

Table 1. Antibodies for immunostaining and results for the present case.

From: Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report

Antibody Clone Source Dilution Immunoreactivity
Ovarian carcinoma Breast tumor
Mucinous, endocervical type (seromucinous) Serous, low grade
WT1 WT49 Leica 1/30 (+) (+++) (+++)
PAX8 BC12 Nichirei RTU (+) (+++) (+++)
CA125 M11 Dako 1/50 (+++) (+++) (+++)
p53 DO-7 Dako 1/2000 wild type wild type wild type
ER SP1 Ventana RTU (+++) (+++) (+++)
PgR 1E2 Ventana RTU (++) (+) (−)
GATA3 HG3-31 Santa Cruz 1/50 (−) (−) (−)
Mammaglobin 304-1A5 Dako 1/500 (−) (−) (−)
GCDFP15 D6 BioLegend 1/500 (−) (−) (−)
HER2 4B5 Ventana RTU (−) (−) (−)
Ki67 MIB1 Dako 1/50 15% 15% 15%
  1. ER estrogen receptor, PgR progesterone receptor, GCDFP15 gross cystic disease fluid protein-15, HER2 human epidermal growth factor-2, RTU ready to use, (+) focal and weak staining, (++) intermediate staining, (+++) diffuse and strong staining